The current status of gene therapy for Parkinson's disease
{{output}}
The recent development of viral vectors, especially vectors derived from adeno-associated virus (AAV), has translated gene therapy for Parkinson's disease (PD) from animal experiments into clinical trials. The current gene therapy protocols used are based on t... ...
